Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.

AUTOR(ES)

Bouvier, M

RESUMO

Recognition of peptides bound to class I major histocompatibility complex (MHC) molecules by specific receptors on T cells regulates the development and activity of the cellular immune system. We have designed and synthesized de novo cyclic peptides that incorporate PEG in the ring structure for binding to class I MHC molecules. The large PEG loops are positioned to extend out of the peptide binding site, thus creating steric effects aimed at preventing the recognition of class I MHC complexes by T-cell receptors. Peptides were synthesized and cyclized on polymer support using high molecular weight symmetrical PEG dicarboxylic acids to link the side chains of lysine residues substituted at positions 4 and 8 in the sequence of the HLA-A2-restricted human T-lymphotrophic virus type I Tax peptide. Cyclic peptides promoted the in vitro folding and assembly of HLA-A2 complexes. Thermal denaturation studies using circular dichroism spectroscopy showed that these complexes are as stable as complexes formed with antigenic peptides.

Documentos Relacionados

• A first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules.
• Mice lacking major histocompatibility complex class I and class II molecules.
• Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.
• Phospholipids enhance the binding of peptides to class II major histocompatibility molecules.
• The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides "in vivo".